Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biochemical and clinical effects of RPS20 expression in renal clear cell carcinoma

9 Dec 2022

Abstract excerpt

Renal cell carcinoma (RCC) remains one of the most lethal urinary tumors in East Asia despite great advancements in treatment strategies in recent years. Ribosomal protein S20 (RPS20) is considered a new oncogene; however, little information is available on its expression, regulation and biological function in patients with RCC. In the present study, 43 pairs of human RCC and neighboring normal renal tissues were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36484407
DOI: 10.3892/or.2022.8459

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biochemical and clinical effects of RPS20 expression in renal clear cell carcinomaPMID 36484407Read ↗

The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarkerSemantic proximity Read ↗

Comprehensive Analysis of the Expression and Prognosis for <i>PSMBs</i> in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

CTHRC1 promotes the progression of clear cell renal cell carcinoma via the PI3K/AKT/GSK3β signaling pathwaySemantic proximity Read ↗

Upregulation of Pole2 Promotes Clear Cell Renal Cell Carcinoma Progression via AKT/mTOR Pathway and Predicts a Poor PrognosisSemantic proximity Read ↗

The tumor promoter role and molecular mechanism of C8orf76/CALB2 axis in clear cell renal cell carcinomaSemantic proximity Read ↗

Overexpression of RNF180 Inhibits Progression and Metastasis by Epithelial Mesenchymal Transformation and Immune Infiltration in Renal CancerSemantic proximity Read ↗

Bioinformatic Analysis Identifying PSMB 1/2/3/4/6/8/9/10 as Prognostic Indicators in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

ESM1 promote proliferation, invasion and angiogenesis via Akt/mTOR and Ras pathway in kidney renal clear cell carcinomaSemantic proximity Read ↗

KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathwaySemantic proximity Read ↗

BAP1 serves as a clear-cell renal cell carcinoma suppressor and is inversely regulated by miR-200c-3pSemantic proximity Read ↗

IL20RB is a Prognostically Significant Gene and a Potential Biomarker in Papillary Renal Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.